Mad Hedge Biotech and Healthcare Letter December 30, 2025 Fiat Lux Featured Trade: (BIOTECH’S WATERLOO: THE STOCKS THAT CONQUERED AND THE ONES THAT DIDN’T) (IDXX), (CAH), (HCA), (COR), (MCK), (GILD), (JNJ), (LLY), (ISRG), (WBA), (MRK), (BMY), (MRNA), (BIIB), (ILMN)
Category Archives: Biotech Letter
Napoleon once said, “In victory, you deserve champagne. In defeat, you need it.” Healthcare investors popped both in 2025. While the sector at large looked like a casualty of macro shrapnel, a few names marched through the battlefield with earnings like artillery fire – and stock prices to match. The top-line view was grim: the […]
Mad Hedge Biotech and Healthcare Letter December 23, 2025 Fiat Lux Featured Trade: (CLIMBING THE CLIFF IN REVERSE) (REGN), (AMGN), (MRK), (BMY), (NVO), (LLY)
A few months ago, I found myself sipping flat champagne on a Gulfstream out of Aspen, locked in one of those altitude-fueled biotech postmortems. On my left: a hedge fund manager freshly out of his biotech positions after a bruising year. On my right: a dermatologist who moonlights as a GLP‑1 evangelist. Regeneron (REGN) came […]
Mad Hedge Biotech and Healthcare Letter December 18, 2025 Fiat Lux Featured Trade: (CHAMPAGNE OR SHAM PAIN?) (AMGN)
You can almost hear the champagne corks popping as Amgen (AMGN) just notched all-time highs and sits comfortably in the portfolios of risk-averse institutions and dividend disciples alike. But in biotech, comfort can be deceptive. Beneath the surface, a patent cliff is forming, a tax storm is brewing, and the pipeline looks more “under renovation” […]
Mad Hedge Biotech and Healthcare Letter December 16, 2025 Fiat Lux Featured Trade: (IN VIVO VERITAS) (CRSP), (VRTX)
Mad Hedge Biotech and Healthcare Letter December 11, 2025 Fiat Lux Featured Trade: (JAKAFI AND THE BEANSTALK) (INCY)
I’ve always had a soft spot for Jack and the Beanstalk. It’s a story about a kid everyone underestimates, who turns out to be sitting on a ladder to a kingdom no one else bothered to climb. Incyte (INCY) reminds me of Jack – not because it’s reckless, but because its most valuable assets are […]
Mad Hedge Biotech and Healthcare Letter December 9, 2025 Fiat Lux Featured Trade: (A PITY PARTY NEVER PAID SO WELL) (PFE)